Zero active COVID-19 cases in Andhra Pradesh
As of May 19, India has recorded 257 COVID-19 cases, with Kerala reporting 95, Tamil Nadu 66, Maharashtra 55, Karnataka 13, and Puducherry 10. However, the Health Department has urged citizens to remain cautious. Common symptoms include fever, cough, cold, and sore throat, and individuals experiencing them should seek medical attention.
Travellers from affected regions are advised to get tested and self-isolate for at least a week if symptomatic. Masks have been made mandatory on public transport and in crowded spaces like shopping malls, cinemas, places of worship, and markets.
A special advisory has been issued for vulnerable groups, including pregnant women, children below five years, senior citizens, and individuals with chronic illnesses. They are encouraged to limit travel and follow strict hygiene practices.
The State government continues to stress preventive measures and urges public cooperation to maintain its safety record.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
10 hours ago
- Time of India
The puberty talk: When to talk, what to talk, and the challenges, according to experts
A recent poll highlights the challenges parents face when discussing puberty with their children, revealing varied approaches and anxieties. Many parents are unsure about the right age to begin the conversation, with some feeling embarrassed or ill-equipped. Experts recommend starting early, being proactive, and utilizing resources to guide children through physical and emotional changes. Talking to kids about puberty is important. But when and how to start the conversation is a grey area for many parents. A new poll has looked deep into the challenges parents face about having 'the puberty talk' with their children. When to start the conversation According to the University of Michigan Health C.S. Mott Children's Hospital National Poll on Children's Health, some of the common challenges that parents face are: choosing the right age to talk about the changes in their children's bodies, and also sex education. The poll found that parents are equally split in thinking it's best to start talking about puberty before age 10, at age 10, or when children are older. 'It's easy to assume a child is too young for conversations about puberty, but many parents are surprised to find their tween already showing signs of puberty or asking unexpected questions about body changes. Starting the conversation early gives parents a chance to shape the message in an age-appropriate way and help kids know what to expect, so they're not confused or anxious. If parents don't open the door to these talks, kids may get their information elsewhere, like from classmates, social media, or what they see on TV,' Mott Poll Co-Director Sarah Clark, M.P.H. , said, in a statement. The polls also found the kinds of approaches, worries, and gaps parents have in their tweens for this major stage of development. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Resmed AirSense 11 with flat 20% off ResMed Buy Now Undo About half of the parents said their approach to the puberty talk was 'proactive'. Two in five had the conversation only when asked. Surprisingly, 5% of the parents avoided the conversation altogether. One in five parents was worried about feeling embarrassed about having the conversation. One in six said they were anxious about saying the wrong thing. Among parents of children aged 10-12, a quarter said their child didn't want to talk about puberty. Parents of those aged 7-9, nearly a third, believed the kids were too young to understand. What to talk During the puberty talk, nearly half of the parents shared their puberty experiences with their children. Less than one-third of the parents shared that they have had the puberty conversation with their children. However, more than a third of the parents revealed that their parents never had this conversation with them. 'Whether they realize it or not, parents may bring their own experiences into their parenting approach. Many parents said they had little or no discussion of puberty when they were young. If puberty was treated as an awkward or embarrassing subject growing up, that can make it harder to know how to begin,' Clark said. How much to talk about puberty Source: CS Mott Children's Hospital National Poll an Children's Health, 2025 The poll revealed that parents have some common challenges, such as whether, when, and how much to talk about sex and reproduction. 'Early conversations should focus on making kids aware that they will experience physical and emotional changes , and reassuring them that those changes are normal. Discussions about sex can occur over time,' Clark said. Clark also recommended that parents look for resources such as parenting books on how to talk to kids. Annual check-ups may also be a good opportunity for both parents and children to learn about puberty-related changes and ask the doctor questions. Recognizing puberty signs The poll revealed that about half of the parents were confident that they could recognise signs of puberty in their children. 60% of parents of children aged 10-12, and 17% parents of children aged 7-9 were able to notice these changes. However, fewer than a third of parents weren't sure what changes to look for. No more guesswork: Doctor busts common myths about women's health Some parents said that their children asked about their bodies, their parents' bodies, or other puberty-related topics. Clark added that parents should be open to discussing when such moments arise. For instance, when the child asks questions about puberty. 'Puberty isn't just about physical changes — it's also a time of emotional disruption, which can make open communication challenging. Many tweens feel embarrassed or uncomfortable talking with their parents about these changes. To help ease the discomfort, some parents may give their child an age-appropriate book or video about puberty and allow the child to explore the topic privately. Often, that leads to additional discussion with parents,' Clark added. Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
United News of India
10 hours ago
- United News of India
Japanese Encephalitis reduced to single digit in UP, spread of AES also down
Lucknow, Aug 3 (UNI) Japanese Encephalitis, which was an epidemic in Purvanchal of Uttar Pradesh till 2017, has currently reduced to a single digit, according to UP health officials. The spread of Acute Encephalitis (AES), another form of JE, has also reduced, they added. Officials said due to the efforts being made by the government against the communicable diseases, Japanese Encephalitis is inching closer to eradication. For the last more than five decades, this disease was synonymous with death in Purvanchal. Every year thousands of children died prematurely. When Chief Minister Yogi Adityanath took over in 2017, he gave the eradication of the disease the form of a mass movement. For this, a coordination committee of 17 departments was formed by keeping the Health Department as the nodal agency. The 17 departments included Urban and rural development, panchayati raj, education department, Jal Jeevan Mission and others. Like every year, this time under the Communicable Disease Campaign which ran from July 1 to July 31 in the state, a cleanliness campaign along with awareness was run in JE and AES-affected districts of Gorakhpur, Kushinagar, Maharajganj, Deoria, Basti, Sant Kabir Nagar, Siddharth Nagar, Azamgarh and Mau. The result is that the scope of this disease has further reduced. According to state surveillance officer Dr Vikasendu Agarwal, this time from January till now, 137 cases of AES have been reported, but there has been no death. Last year 332 AES cases were reported. However, only 4 cases of JE have been reported this time. Last year, 18 such cases came to light. Similarly, this time only one case of Kala Azar has been found in the state, whereas 827 cases of dengue have been detected. Last year this figure was 451. Similarly, this time 129 cases of Chikungunya have been reported, whereas last year, the figure was 128. This time 7,419 cases of malaria have been reported. Last year this figure was 3,013. Regarding the increase in dengue cases, doctors say that it increases every third year. Therefore, there are chances of an uptick this time. Monsoon rain is also being cited as a reason behind malaria cases. UNI MBD PRS
Economic Times
12 hours ago
- Economic Times
Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccine
In a landmark advancement for oncology and personalized medicine, Russia's Gamaleya National Research Center of Epidemiology and Microbiology—the creators of the Sputnik V COVID-19 vaccine—announced this year that it will begin human clinical trials of the world's first personalized mRNA-based melanoma vaccine within the next few months. Alexander Gintsburg, director of the Gamaleya Center, confirmed that this groundbreaking vaccine, tailored specifically to the genetic profile of individual patients' tumors, will start experimental administration as early as September-October 2025 in collaboration with leading Russian oncology institutions. Q. What are melanoma cellsA. Melanoma cells come from melanocytes, the skin cells that give it color. When these cells grow too much and become cancerous, they cause melanoma, a dangerous kind of skin cancer that can spread fast if not treated early. Q. What is mRNA, and how is it used in vaccines? A. mRNA, or messenger RNA, is a molecule that carries genetic instructions from DNA to the cell's protein-making machinery. It acts like a messenger, conveying the code needed to build specific proteins that perform various functions in the body. In vaccines, mRNA teaches cells to produce a harmless piece of a virus or cancer antigen, triggering the immune system to respond and protect the body. This novel cancer vaccine is designed to train the immune system to recognize and attack melanoma cells by creating a bespoke mRNA blueprint derived from each patient's unique tumor mutations. The process involves sophisticated artificial intelligence algorithms that analyze the tumor's genetic data to produce a molecular template, which is then synthesized at Gamaleya's production facilities. This tailor-made mRNA encodes proteins that activate a targeted cytotoxic immune response, aiming not only to eradicate primary tumors but also to address metastatic cancer elaborated that the entire vaccine development cycle—from tumor sequencing to vaccine production—can be completed within about one week due to AI-assisted mathematical modeling and neural network computing. This rapid manufacture represents a significant leap compared to typical timelines in personalized cancer therapies. Q. What is a personalized cancer vaccine?A. Personalized cancer vaccine is a tailored immunotherapy designed to train the patient's immune system to recognize and attack their specific cancer cells. It uses information from the patient's tumor genetics to create a unique vaccine that targets tumor-specific mutations, differing from general vaccine model was developed starting in mid-2022 and has already demonstrated promising efficacy in preclinical animal studies, showing the ability to suppress tumor growth and reduce metastasis. The upcoming Phase I clinical trials will take place at two of Russia's foremost oncology centers: the Hertsen Research Institute and the N.N. Blokhin National Medical Research Center of Oncology in Moscow. Importantly, this tailored vaccine is part of a wider Russian initiative to advance cancer treatment across various difficult-to-treat types, including pancreatic, kidney, and non-small-cell lung cancers. The Russian Ministry of Health classifies this vaccine development and approval under a new, specialized regulatory process recognizing its individualized nature, differing fundamentally from traditional drug registration. The state plans to provide this cancer vaccine free of charge to Russian citizens, with an estimated production cost of around 300,000 rubles (approx. USD 2,869) per dose covered by government to health authorities, about 4 million Russians live with cancer, and approximately 625,000 new cancer cases are diagnosed annually, underlining the urgent need for innovative therapies. The vaccine's success could mark a pivotal moment in Russia's fight against cancer and elevate its personalized medicine the COVID-19 mRNA vaccines designed to target a single viral antigen, this personalized cancer vaccine encodes multiple neoantigens specific to each patient's tumor, offering a multi-targeted immune approach.
